Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxil in Recurrent or Advanced Uterine Leiomyosarcoma
NCT00005643Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- May 2000
- Primary completion
- Mar 2005
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 2
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin in uterine sarcoma, sponsored by GOG Foundation. Started May 2000; status: completed.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
uterine sarcoma
Beyond the preview
Go deeper on NCT00005643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005643.